BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dune Medical Devices Ltd. Release: MarginProbe® System to be Installed at the Largest Breast Center in Frankfurt, Germany


9/27/2012 9:57:16 AM

FRAMINGHAM, Mass., Sept. 27, 2012 /PRNewswire/ -- Dune Medical Devices announced today that the MarginProbe System will be used at the Agaplesion Markus Hospital, in Frankfurt, Germany. The Agaplesion Markus Hospital is the largest breast center in the Frankfurt area, treating over 400 primary breast cancer cases annually.

"In my previous work with the MarginProbe System, we saw a significant reduction in the number of patients who had to come back for additional surgeries due to positive margins," said Priv.-Doz. Dr. med. Marc Thill, Head of the Department of Gynecology and Obstetrics and the Breast Cancer Center at Agaplesion Markus Hospital, Frankfurt. "We are thrilled to make this innovation available to patients here in Frankfurt. I believe that this technology represents a real breakthrough for breast conserving surgery."

"Our collaboration with Dr. Thill and the Agaplesion Markus Hospital is a terrific boost for patients in Frankfurt," says Dune's Chief Executive Officer Dan Levangie. "By reducing the chances of going back for multiple surgeries, the MarginProbe system can significantly improve patients' experiences being treated for breast cancer. We are excited to continue to work with Dr. Thill at Agaplesion Markus Hospital."

About Dune Medical Devices
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. The MarginProbe System is Dune's first commercial product and is commercially available in Europe. The MarginProbe device is an investigational device that is not yet available for sale in the U.S.

Dune Medical Devices is a privately held company financed by Apax Partners since 2004. It has offices in the U.S., Israel, and Switzerland. For more information, please visit www.dunemedical.com

Contact:
Michael Graffeo, Director of Marketing, Dune Medical Devices
508-620-2782 / michael.graffeo@dunemedical.com

SOURCE Dune Medical Devices



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES